Reshma Kewalramani, CEO & President: Vertex Pharmaceuticals VRTX Sell · Filed 23/12/19

Trade details

Type: Insider sale
Amount: $6,973,945
Shares · price: 17,135 sh · $407.00 a share
Held after: 108,711 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Reshma KewalramaniCEO & President
Trade date: 23/12/15
Filed: 23/12/19
Days to filing: 4 days

Sold 13.6% of holdings

Share of holding sold: 13.6%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/11/15~24/01/14

Reshma Kewalramani's recent trades

Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.7M
15,580 sh
$7.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3M
5,995 sh
$3M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.7M
3,498 sh
$1.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,278 sh
$1.6M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,725 sh
$1.3M
Filed 03/03
Traded 02/27

Reshma Kewalramani, CEO — sold $7M of Vertex Pharmaceuticals VRTX · 13.6% of holdings · 10b5-1 plan | Whalegun